Your browser doesn't support javascript.
loading
Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT.
Sun, Qian; Li, Xiaozhe; Gu, Jingli; Huang, Beihui; Liu, Junru; Chen, Meilan; Li, Juan.
Afiliación
  • Sun Q; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Li X; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Gu J; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Huang B; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Liu J; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Chen M; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Li J; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Front Oncol ; 12: 776920, 2022.
Article en En | MEDLINE | ID: mdl-35664799

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China